Chiesi RinoClenil nasal spray

RinoClenil is a specialized nasal spray treatment manufactured and owned by Chiesi Farmaceutici, a prominent Italian pharmaceutical company. The product is primarily used for the prophylaxis and treatment of allergic and vasomotor rhinitis, containing beclomethasone dipropionate as its active ingredient.

Founded in Parma, Italy, Chiesi remains an independent, family-controlled international research-focused group. While the company has a global presence with products distributed in more than 100 countries and several production sites worldwide, RinoClenil is a core part of its respiratory portfolio with a strong manufacturing base in Italy. The brand belongs entirely to Chiesi Farmaceutici S.p.A., which continues to lead the brand's development and distribution into 2026 and beyond.